Allied Healthcare Products, Inc. (AHPI) Stock Analysis
DELISTED 2023
What happened to Allied Healthcare Products, Inc. (AHPI) stock?
Allied Healthcare Products, Inc. (AHPI) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Allied Healthcare Products, Inc. (AHPI) trades at $0.004. Allied Healthcare Products, Inc. manufactures and markets a comprehensive range of respiratory products and medical gas equipment globally. The company serves hospitals, home healthcare providers, and emergency medical services. Sector: Healthcare.
Last analyzed: Mar 18, 2026Analyst Coverage for AHPI: AHPI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AHPI against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Allied Healthcare Products, Inc. (AHPI) Healthcare & Pipeline Overview
Allied Healthcare Products, Inc. specializes in manufacturing and distributing respiratory care and medical gas equipment for hospitals, home healthcare, and emergency services. With a focus on a broad product portfolio, the company operates worldwide, providing essential medical devices and related products to diverse healthcare settings.
What Is the Investment Thesis for AHPI?
Allied Healthcare Products operates in the stable medical devices market, providing essential respiratory and medical gas equipment. The company's diverse product portfolio and established distribution network offer a degree of resilience. However, negative beta of -2.40 suggests the stock moves inversely to the market, which could be a risk during market upturns. Growth catalysts include expanding the product line and penetrating new geographic markets. Investors should monitor the company's ability to innovate and adapt to changing healthcare regulations.
Based on FMP financials and quantitative analysis
AHPI Key Highlights
Allied Healthcare Products serves a range of hospitals and alternate site settings worldwide, indicating a broad market reach.
- The company's product portfolio includes respiratory care/anesthesia products, medical gas equipment, and emergency medical products, offering diversification.
- Allied Healthcare Products distributes products through various channels, including hospital equipment dealers, home health care dealers, and emergency medical product dealers.
- The company headquarters is in St. Louis, Missouri, providing a central location for manufacturing and distribution.
- The company was incorporated in 1979, demonstrating a long-standing presence in the healthcare industry.
Who Are AHPI's Competitors?
AHPI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CFMS Conformis, Inc. | $2.27 | +0.44% | $17.9M | 46 |
| ABT Abbott Laboratories | $114.26 | -0.15% | $198B | 70 |
| SYK Stryker Corporation | $340.11 | +0.04% | $131B | 79 |
| MDT Medtronic plc | $92.88 | -1.33% | $119B | 77 |
| BSX Boston Scientific Corporation | $52.01 | +3.05% | $77.3B | 80 |
| EW Edwards Lifesciences Corporation | $89.83 | -2.65% | $51.7B | 93 |
| DXCM DexCom, Inc. | $89.92 | +0.04% | $33.9B | 93 |
| STE STERIS plc | $236.91 | +1.95% | $24.0B | 85 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AHPI's Key Strengths?
Comprehensive product range in respiratory care.
- Established distribution network.
- Long-standing presence in the healthcare industry.
- Expertise in medical gas equipment.
What Are AHPI's Weaknesses?
High dependence on traditional product lines.
- Limited presence in emerging markets.
- Negative beta indicating inverse market correlation.
- Small company size limits R&D investment.
What Could Drive AHPI Stock Higher?
Potential new product launches in the respiratory care segment.
- Expansion of distribution network in key geographic regions.
- Strategic partnerships with healthcare providers to enhance market reach.
What Are the Key Risks for AHPI?
Financial-distress signal — its Altman Z-Score of -0.28 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Increased competition from larger medical device companies.
- Stringent regulatory requirements impacting product development and approval.
- Economic downturns affecting hospital budgets and capital expenditures.
What Are the Growth Opportunities for AHPI?
- Expansion into Home Healthcare Market: The increasing demand for home healthcare products presents a significant growth opportunity for Allied Healthcare Products. By expanding its line of home respiratory care products, including portable oxygen concentrators and nebulizers, the company can tap into this growing market. The global home healthcare market is projected to reach $360 billion by 2028, offering substantial revenue potential. Timeline: 2-3 years.
- Geographic Expansion into Emerging Markets: Entering emerging markets in Asia-Pacific and Latin America can drive growth. These regions have increasing healthcare expenditures and a growing need for respiratory care products. By establishing partnerships with local distributors and tailoring products to meet regional needs, Allied Healthcare Products can penetrate these markets. The emerging markets healthcare sector is expected to grow at a CAGR of 8-10% over the next five years. Timeline: 3-5 years.
- Product Innovation and Development: Investing in research and development to create innovative respiratory products can provide a competitive edge. Developing advanced ventilators, oxygen therapy systems, and monitoring devices can attract new customers and increase market share. The global respiratory devices market is projected to reach $35 billion by 2027, driven by technological advancements. Timeline: Ongoing.
- Strategic Acquisitions and Partnerships: Acquiring smaller companies with complementary product lines or forming strategic partnerships with healthcare providers can expand Allied Healthcare Products' market reach and product offerings. This can also provide access to new technologies and distribution channels. The medical device industry is witnessing increasing consolidation, with strategic acquisitions playing a key role in growth. Timeline: 1-3 years.
- Telehealth Integration: Integrating telehealth capabilities into respiratory care products can improve patient monitoring and remote management. Developing connected devices that transmit data to healthcare providers can enhance patient outcomes and reduce hospital readmissions. The telehealth market is experiencing rapid growth, driven by advancements in technology and increasing demand for remote healthcare services. Timeline: Ongoing.
What Are AHPI's Competitive Advantages?
- Established brand reputation in the respiratory care market.
- Diverse product portfolio catering to various healthcare settings.
- Long-standing relationships with hospitals and healthcare providers.
- Specialized expertise in medical gas equipment and systems.
What Does AHPI Do?
Incorporated in 1979 and headquartered in St. Louis, Missouri, Allied Healthcare Products, Inc. has established itself as a manufacturer and marketer of respiratory products crucial to the healthcare industry. The company's comprehensive product range caters to hospitals and alternate site settings worldwide. Allied Healthcare Products offers a diverse portfolio, including respiratory care/anesthesia products such as air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers. Additionally, they provide respiratory disposable products like oxygen tubing, facemasks, cannulas, and ventilator circuits. The company also offers home respiratory care products, including aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, and portable suction equipment. Allied Healthcare Products' medical gas equipment segment features in-wall medical system components, central station pumps and compressors, and headwalls. They also supply regulation devices and suction equipment, including flowmeters, vacuum regulators, and pressure regulators, along with related adapters, fittings, and hoses. These products are essential for measuring, regulating, monitoring, and transferring medical gases. Furthermore, the company provides emergency medical products, including respiratory/resuscitation products like demand resuscitation valves, portable resuscitation systems, bag masks, emergency transport ventilators, and trauma and patient handling products, such as spine immobilization products and pneumatic anti-shock garments. The company serves a broad customer base, including hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, and emergency medical product dealers.
What Products and Services Does AHPI Offer?
- Manufactures air compressors for respiratory therapy.
- Produces calibration equipment for medical devices.
- Offers humidifiers and croup tents for respiratory care.
- Provides oxygen tubing, facemasks, and cannulas.
- Manufactures aluminum oxygen cylinders and oxygen regulators.
- Offers portable suction equipment for emergency medical use.
- Supplies medical gas equipment, including flowmeters and regulators.
- Provides emergency resuscitation products and trauma care equipment.
How Does AHPI Make Money?
- Manufacturing and selling respiratory care and anesthesia products.
- Providing medical gas equipment and related components.
- Offering emergency medical products, including resuscitation and trauma care equipment.
- Distributing products through hospitals, home healthcare dealers, and emergency medical product dealers.
What Industry Does AHPI Operate In?
The medical devices industry is characterized by continuous innovation, stringent regulatory requirements, and increasing demand driven by an aging population and advancements in healthcare. Allied Healthcare Products operates within this landscape, focusing on respiratory and medical gas equipment. The industry is competitive, with companies like CFMS and EQUR offering similar products. Market trends include a growing emphasis on home healthcare and portable medical devices, presenting both opportunities and challenges for Allied Healthcare Products.
Who Are AHPI's Key Customers?
- Hospitals and acute care facilities.
- Home healthcare providers and patients.
- Emergency medical services (EMS) and first responders.
- Hospital equipment dealers and distributors.
- Hospital construction contractors.
Company Profile
Allied Healthcare Products, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Saint Louis, US. The company is led by CEO Daniel C. Dunn. AHPI has traded publicly since 1992.
Key Financial Metrics
Return on equity for Allied Healthcare Products, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. AHPI trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Allied Healthcare Products, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.28 places it in the distress zone, a signal of elevated financial risk.
AHPI Financials
Bull Case vs Bear Case
Bull Case
- Comprehensive product range in respiratory care.
- Established distribution network.
- Long-standing presence in the healthcare industry.
- Expertise in medical gas equipment.
Bear Case
- High dependence on traditional product lines.
- Limited presence in emerging markets.
- Negative beta indicating inverse market correlation.
- Small company size limits R&D investment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
AHPI Latest News
No recent news available for AHPI.
Leadership: Daniel C. Dunn
CEO
Daniel C. Dunn serves as the CEO of Allied Healthcare Products, Inc. His background includes extensive experience in managing and leading organizations, with a focus on operational efficiency and strategic growth. He has a proven track record in the healthcare industry, demonstrating expertise in product development, market expansion, and financial management. His leadership is aimed at driving innovation and enhancing shareholder value.
Track Record: Under Daniel C. Dunn's leadership, Allied Healthcare Products has focused on maintaining its market position in respiratory care and medical gas equipment. Key achievements include streamlining operations and expanding the product portfolio to meet evolving customer needs. His strategic decisions have aimed at improving profitability and ensuring long-term sustainability.
AHPI Healthcare Stock FAQ
What happened to Allied Healthcare Products, Inc. (AHPI) stock?
Allied Healthcare Products, Inc. (AHPI) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
Can I still buy AHPI shares?
No. AHPI stopped trading on public markets in February 2023, so the shares are not available through a broker. Anything you see quoted for AHPI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AHPI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Allied Healthcare Products, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Allied Healthcare Products, Inc. do?
Allied Healthcare Products, Inc. manufactures and markets a range of respiratory products and medical gas equipment for use in various healthcare settings worldwide. The company's offerings include respiratory care/anesthesia products, medical gas equipment, and emergency medical products. These products serve hospitals, home healthcare providers, and emergency medical services, supporting patient care and treatment.
What are the main risks for AHPI?
The main risks for Allied Healthcare Products include intense competition from larger medical device companies, stringent regulatory requirements and compliance costs, and potential technological advancements rendering existing products obsolete. Economic downturns could also affect hospital budgets and capital expenditures, impacting demand for the company's products. The negative beta of -2.40 indicates the stock's inverse correlation with the market, posing a risk during market upturns.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- AI analysis pending.